4//SEC Filing
VANLENT ANNE 4
Accession 0001209191-23-040290
CIK 0001563880other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:00 PM ET
Size
5.6 KB
Accession
0001209191-23-040290
Insider Transaction Report
Form 4
VANLENT ANNE
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2023-06-28+30,000→ 30,000 totalExercise: $2.27Exp: 2033-06-27→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 28, 2023. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001229243
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:00 PM ET
- Size
- 5.6 KB